Clonal hematopoiesis and blood-cancer risk

New England Journal of Medicine

Volumn 372, Issue 11, 2015, Pages 1071-1072

  Yan, Benedict ^a   Ban, Kenneth ^a   Chng, Wee Joo ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN;

ALGORITHM; CANCER RISK; CLONAL HEMATOPOIESIS; FLT3 GENE; GENE DUPLICATION; GENE MUTATION; GENETIC VARIABILITY; GENOME ANALYSIS TOOLKIT ALGORITHM; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; INTERNAL TANDEM DUPLICATION; LETTER; MUTATIONAL ANALYSIS; PINDEL ALGORITHM; PRIORITY JOURNAL; COMPUTER PROGRAM; EXOME; MISSENSE MUTATION; SEQUENCE ANALYSIS; BLOOD; CELL TRANSFORMATION; GENETICS; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; MUTATION; PHYSIOLOGY;

BLOOD; CELL TRANSFORMATION, NEOPLASTIC; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MUTATION;

EID: 84924691959     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1500684     Document Type: Letter

References (3)

1. Genovese G, Kähler AK, Handsaker RE, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 2014;371:2477-87.
2. Spencer DH, Abel HJ, Lockwood CM, et al. Detection of FLT3 internal tandem duplication in targeted, short-read-length, nextgeneration sequencing data. J Mol Diagn 2013;15:81-93.
3. Luthra R, Patel KP, Reddy NG, et al. Next-generation sequencingbased multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring. Haematologica 2014;99:465-73.